Metraipolis › archive › dc_48003cce4ea6

Mapping the evidence supporting FDA-authorized digital therapeutics, before and after authorization — Europe PMC PMID:42162261

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42162261
DOI
10.1038/s41746-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-01T13:36:49.276Z
SHA-256 of the archived text
b79572970679ec4acb2913482e3df49c9cb1052488cd7769140b364406b815f5
Stable URL of this page
https://metraipolis.com/documento/dc_48003cce4ea6

How to cite

Mapping the evidence supporting FDA-authorized digital therapeutics, before and after authorization — Europe PMC PMID:42162261 — Europe PMC (en), https://europepmc.org/article/MED/42162261 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_48003cce4ea6 (Metraipolis archive dc_48003cce4ea6, sha256 b79572970679ec4acb2913482e3df49c9cb1052488cd7769140b364406b815f5)
BibTeX
@misc{dc48003cce4ea6,
  title = {Mapping the evidence supporting FDA-authorized digital therapeutics, before and after authorization — Europe PMC PMID:42162261},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42162261},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_48003cce4ea6; sha256 b79572970679ec4acb2913482e3df49c9cb1052488cd7769140b364406b815f5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42162261. Agents can read the archived copy with the MCP tool read_document.